In this interview, Professor Wojciech Jurczak presents and discusses the primary results of ASSIST-FL, the confirmatory, PhIII randomised, double blinded efficacy study of Sandoz rituximab biosimilar.
This content is intended for healthcare professionals. By accessing it, you confirm that you are a healthcare professional.
This video was funded by Sandoz.
